Skip to main content
Pay Bill Portals

Seeing beyond the limit: Detect residual disease and assess treatment response

Published Date

Summary of analytical and clinical data for Signatera™, the first ctDNA assay custom-built for MRD detection and treatment response.

Download PDF

Summary of analytical and clinical data for Signatera™, the first ctDNA assay custom-built for MRD detection and treatment response.